Pharmidex partners in European Commission H2020 award
May 21, 2017

Pharmidex joins Horizon 2020 EU project to work on radioactive contamination

Pharmidex partners in European Commission H2020 award

This project aims to stimulate intersectoral and international collaboration within Europe and with an ICPC country, Kazakhstan, in the area of novel nanoporous and nanostructured adsorbents for the treatment of very serious health conditions associated with acute and chronic exposure to external radiation and uptake of heavy metals and radiation as a consequence of accidental, occupational or deliberate activities and events.


This can dramatically lower the quality of life of the people affected and at present the treatment available is costly and inefficient. Radioactive contamination is a particularly serious problem in two of the countries participating in this project, namely, Ukraine and Kazakhstan, on large territories of the Chernobyl zone and around Semipalatinsk nuclear test site, respectively.


A large number of people are affected by living in the areas with elevated level of radioactivity with uncertain long-term consequences to their health and the health of future generations.


The expected impact of the project results is development of efficient and cost-effective methods of protection of first responders, population and cancer patients treated with radiotherapy from elevated doses of external and incorporated radiation and for occupational health protection of personnel working and the population living in areas contaminated with heavy metals.


Please find more information on the following web page: http://cordis.europa.eu/project/rcn/207057_en.html

Pharmidex at ON Helix 2025
July 2, 2025
We’re excited that Ash Alavijeh (Head of Operations) and Ian Knowles (Head of Respiratory) will attend ON Helix 2025 on 3 July in Cambridge, UK .  They look forward to meeting fellow attendees and exploring new ways to collaborate in drug discovery and development . 📍 https://www.onhelix.com
Milner Therapeutics Symposium 2025
June 30, 2025
We’re excited that Ash Alavijeh (Head of Operations) and Janette Robertson (Business Development Manager) will attend the Milner Therapeutics Symposium on 30 June 2025 in Cambridge.  They look forward to connecting with attendees and discussing how Pharmidex can support collaboration and innovation in drug discovery. 📍 https://milner.glueup.com/event/milner-therapeutics-symposium-2025-132179/home.html
June 27, 2025
At Pharmidex our CNS team are specialists in microdialysis, with over 30 years of experience in the technique.  Our team combines the technique with powerful analytical techniques, allowing us to measure 13 different analytes in addition to test compounds in each sample. This method allows for detailed Pharmacokinetic and Pharmacodynamic profiling. 🎯 Dual probe or single probe | 🔬 Murine models | ⏳ Real-time PK/PD Ready to add this to your CNS programme? Let's talk.
More Posts